Jentadueto

Indicated For

type 2 diabetes

About This Medication

# Boehringer Cares Patient Assistance Program Patient Guide: How to Get Jentadueto at Low or No Cost Jentadueto (linagliptin/metformin) is a prescription medication used to help manage **type 2 diabetes** in adults, alongside diet and exercise. The **Boehringer Cares Patient Assistance Program** from Boehringer Ingelheim offers this drug at low or no cost to eligible patients who are uninsured or underinsured and meet income guidelines.[1] ## About Jentadueto Jentadueto combines two active ingredients: **linagliptin**, a DPP-4 inhibitor that helps the body release more insulin after meals, and **metformin**, a biguanide that reduces glucose production in the liver and improves insulin sensitivity. It's taken orally, usually twice daily with meals, to control blood sugar levels and reduce the risk of diabetes complications like heart disease or kidney problems. Always follow your doctor's instructions, as dosage varies based on your needs (e.g., 2.5 mg/500 mg, 2.5 mg/850 mg, or 2.5 mg/1,000 mg strengths). Common side effects include stomach upset, diarrhea, or low blood sugar (hypoglycemia) when combined with other diabetes meds. Contact your doctor if you experience severe symptoms like lactic acidosis (rare but serious with metformin).[2] This program helps make Jentadueto accessible when costs are a barrier, providing free medication for up to one year, with options for renewal. ## Who Qualifies? Eligibility focuses on financial need, lack of coverage, and U.S. residency. Key criteria include: - **Residency**: Must live in the United States. - **Age**: Primarily for adults 18+, though some programs cover children—confirm via phone.[1] - **Financial Status**: Needs-based household income evaluation. Specific thresholds (e.g., % of Federal Poverty Level) are not publicly listed online and vary; call (800) 556-8317 for your situation.[1] - **No Recent Resources**: Cannot have received >$10,000 in liquid assets recently (e.g., savings, stocks). The program is designed for those struggling to afford medications despite efforts to access other aid. ## Income Eligibility Breakdown Income limits are household-based and needs-driven, often tied to **Federal Poverty Level (FPL)** percentages (typically 400-500% FPL for similar programs, but confirm current details).[1] Since exact figures aren't specified online, use this general table as a guide—**always verify by calling the program** as guidelines update (last known update: 11/11/2025).[1] | Household Size | Estimated Max Annual Income (e.g., 400% FPL, 2026 est.) | Notes | |---------------|-------------------------------------------------------|-------| | 1 (Individual) | ~$60,000 | Needs-based; assets counted | | 2 (Couple) | ~$81,000 | Include all household income | | 3 | ~$102,000 | Proof required for all earners | | 4 | ~$123,000 | Larger families: add ~$21,000 per person | *Table is illustrative based on standard PAP trends; actual thresholds may differ. Provide pay stubs, tax returns, etc., for review.*[1] ## Insurance Requirements The program targets those with limited coverage: - **Uninsured**: No prescription insurance. - **Underinsured**: Have coverage but high copays, gaps, or denials for Jentadueto. - **Medicare Part D**: Eligible if no other coverage and in the coverage gap (donut hole) or post-gap. - **Exclusions**: Not for those with adequate commercial insurance, Medicaid, VA benefits, or other government programs covering the drug.[1] Submit proof of insurance status (e.g., denial letter, benefits summary). ## Step-by-Step Application Process Applications are available via **multiple methods**—doctor's office, patient self-submission, or phone.[1] Here's how: 1. **Consult Your Doctor**: Discuss Jentadueto and program eligibility. They complete the prescriber section. 2. **Gather Documents**: - Completed enrollment form (download from Boehringer site or request by phone). - **Proof of residency** (utility bill, lease). - **Proof of income** (last 3 pay stubs, tax return, SSI/SSDI letter). - **Healthcare coverage documentation** (insurance card, denial letter, or uninsured affidavit).[1] 3. **Submit Application**: - Call **(800) 556-8317** (Mon-Fri, 9 AM-8 PM ET) for forms/help. - Fax/mail to provided address (given on call/form). - No online portal listed; phone is primary.[1] 4. **Wait for Approval**: Review takes 2-4 weeks typically. 5. **Receive Medication**: Shipped free to your home or doctor's office.[1] **Tip**: Apply early; start with a pharmacist or social worker for support. ## Timeline and Delivery - **Processing**: 2-4 weeks after complete submission (delays if docs missing).[1] - **Approval Duration**: Up to 12 months supply, then **reauthorization required** (resubmit proof).[1] - **Delivery**: Free shipping to patient address or prescriber's office. Track via program contact. - **Refills**: Automatic for approved period; notify of address changes.[1] ## Alternatives if Denied If ineligible: - **Other PAPs**: Check RxAssist.org for Jentadueto alternatives or generics (linagliptin/metformin).[1] - **State Programs**: Medicaid expansion, state pharmaceutical aid. - **Discount Cards**: GoodRx, SingleCare for copay savings. - **Manufacturer Coupons**: Boehringer savings card for commercially insured (pro.boehringer-ingelheim.com).[2] - **Generic Options**: Lower-cost versions if available. - **NeedyMeds.org** or PAN Foundation for copay help. Appeal denials by calling with more info. ## Disclaimer This guide is for informational purposes only and based on available data as of last update (11/11/2025).[1] Eligibility, terms, and income limits can change—**contact Boehringer Cares at (800) 556-8317 to confirm current details**. Not medical advice; consult your healthcare provider. Boehringer Ingelheim reserves rights to modify/discontinue the program. Word count: 1028.

Program information last verified: March 30, 2026